Methanol toxicity,Blunt abdominal trauma according to emergency book medicine

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have all the material needed for a comprehensive answer from ROSEN's and Tintinalli's Emergency Medicine. Here is the full response:

Methanol Toxicity

Sources: ROSEN's Emergency Medicine (9th ed.) and Tintinalli's Emergency Medicine (9th ed.)

Pharmacology / Sources

Methanol (methyl alcohol, "wood alcohol") is a clear, colorless, slightly sweet liquid. Common sources include:

Windshield washer fluid, antifreeze, paint removers, cleaning solutions, embalming fluid
Camp stove fuel, industrial solvents, adhesives, enamels

It is rapidly absorbed from the GI tract (absorptive half-life ~5 minutes, peak concentration at 30-60 minutes). Significant toxicity can also occur via inhalation and transdermal routes in occupational settings (painting, varnishing, lithography).

Metabolism and Mechanism of Toxicity

Fig. Metabolism of methanol - ROSEN's Emergency Medicine

Methanol itself is only mildly toxic. The toxicity is entirely due to its metabolites:

Methanol → (alcohol dehydrogenase / ADH) → Formaldehyde (half-life 1-2 min)
Formaldehyde → (aldehyde dehydrogenase / ALDH) → Formic acid (formate)
Formic acid → (folate-dependent pathway / THF synthetase) → CO₂ + H₂O

Formic acid is the key toxic metabolite. Its mechanisms of harm:

Binds cytochrome oxidase and blocks oxidative phosphorylation → anaerobic metabolism → lactic acidosis
Increases NADH/NAD+ ratio → favors pyruvate → lactate conversion (worsens lactic acidosis)
At lower pH, more formic acid exists in undissociated form, crossing tissue barriers more readily → greater CNS and ocular toxicity
Acidosis also increases tubular reabsorption of formic acid, prolonging its elimination

Kinetics: At toxic concentrations, metabolism follows zero-order kinetics; blood methanol falls at ~8.5 mg/dL/hour. With ADH inhibition, the half-life of methanol extends to >50 hours.

Latency: Symptoms may be delayed 12-24 hours because metabolite formation (not methanol itself) drives toxicity. If ethanol is co-ingested, onset is further delayed as ethanol competes for ADH.

Clinical Features

System	Features
CNS	Headache, vertigo, dizziness, seizures, coma; bilateral putamen necrosis on CT
Ocular	Photophobia, blurred or "snow field" vision, papilledema, non-reactive mydriasis (indicates permanent damage), nystagmus (rare)
GI	Abdominal pain, nausea, vomiting, gastritis, pancreatitis; transaminitis (mild/transient)
Cardiovascular	Tachycardia, hypotension, shock in severe cases
Respiratory	Tachypnea (compensating for metabolic acidosis) → may progress to respiratory failure
Renal	Rhabdomyolysis, renal failure (severe cases)

Key prognostic markers: Coma + seizures + severe metabolic acidosis on presentation = poor outcome. The severity of poisoning correlates more with the degree of acidosis than with the methanol level itself.

Diagnosis / Labs

Anion-gap metabolic acidosis with elevated formate
Elevated osmolar gap (measured osmolality - calculated osmolality > 10 mOsm/L) - seen early before metabolite formation
Serum methanol level (send immediately; results may be delayed)
ABG: low pH, low bicarbonate
Serum lactate (elevated due to formate's blockade of oxidative phosphorylation)
Non-contrast head CT before anticoagulation: may show putamen necrosis, subcortical white matter damage, intracranial hemorrhage

Important: An osmolar gap can be normal late in poisoning (after parent alcohol is largely metabolized to formate), while anion gap acidosis is maximal. Both gaps should be considered together.

Management

1. Supportive Care

ABC management; intubation if needed for airway protection
IV fluids, cardiac monitoring
Sodium bicarbonate for severe acidosis (pH <7.0-7.1): helps prevent formic acid from crossing into tissues

2. ADH Blockade (Metabolic Blockade) - Fomepizole (First-line)

Indications for initiating ADH blockade (Box 136.1, ROSEN's):

Documented plasma methanol ≥ 20 mg/dL, OR
History of ingestion + osmolar gap > 10 mOsm/L, OR
Strong clinical suspicion + at least 2 of: pH < 7.3 | HCO₃ < 20 mEq/L | osmolar gap > 10 mOsm/L

Do not wait for confirmatory levels if clinical suspicion is high - treat empirically.

Fomepizole dosing (Box 136.2, ROSEN's):

Loading dose: 15 mg/kg IV
Maintenance: 10 mg/kg IV every 12 hours (for up to 48 h)
After 48 h: 15 mg/kg every 12 h (auto-induction of CYP450 metabolism)
During hemodialysis: same doses but every 4 hours (fomepizole is dialyzed out)
Continue until methanol < 20 mg/dL (< 6 mmol/L) AND metabolic acidosis resolved

Side effects: headache, nausea, dizziness, phlebitis, transient transaminase elevation. No absolute contraindications (except known allergy - none reported).

Ethanol as alternative (if fomepizole unavailable):

Maintain serum ethanol 100-150 mg/dL; ADH has 10x greater affinity for ethanol than methanol
Oral protocol (80-proof liquor): loading 1.5-2 mL/kg, maintenance 0.2-0.5 mL/kg/hr
Double maintenance dose during dialysis
Risk: CNS/respiratory depression, hypoglycemia (especially in children/malnourished), complex dosing

3. Hemodialysis (HD)

Indications (ROSEN's):

pH < 7.3
Visual abnormalities
Renal failure
Electrolyte imbalances unresponsive to therapy (e.g., hyperkalemia)
Hemodynamic instability
Methanol concentration > 50 mg/dL

HD removes both parent methanol and formate, corrects acidosis, and shortens hospital course (important given methanol's 50+ hour half-life with ADH blockade). Intermittent HD is preferred over continuous renal replacement therapy (CRRT) but CRRT is acceptable if HD unavailable.

4. Folinic Acid (Leucovorin)

Aids formic acid elimination via THF synthetase pathway
Dose: 1 mg/kg IV (max 50 mg) every 4-6 hours until methanol is eliminated and acidosis resolves
No human trial proof of efficacy, but use does not delay or replace HD when indicated

5. Disposition

Admit for all patients being treated
Early nephrology consult for HD
Ophthalmology consult within 24 hours to evaluate retina and visual fields
Transfer to HD-capable facility if not available locally
Contact regional poison center (USA: 1-800-222-1222) or medical toxicologist
Discharge only if methanol < 20 mg/dL with no symptoms or lab abnormalities

Blunt Abdominal Trauma (BAT)

Sources: ROSEN's Emergency Medicine and Tintinalli's Emergency Medicine

Epidemiology and Mechanisms

The most common cause of BAT is motor vehicle collision (MVC). Falls are second in frequency. Pedestrians struck by vehicles, motorcyclists, and bicyclists are at especially high risk. Forces involved: compression, shearing/stretching, and acceleration/deceleration.

Most commonly injured organs:

Spleen - most common; isolated injury in ~two-thirds of cases
Liver - second most common
Hollow viscus (small bowel) - uncommon but important (CT is less sensitive for these injuries)

Clinical Features

Signs range from subtle to severe shock. Diagnosis is challenging because:

Concomitant injuries (especially head trauma) may mask or distract from abdominal findings
Intoxication or altered mental status limits examination reliability
Young, healthy patients may compensate for significant hemorrhage before vital sign changes appear
Elderly patients on beta-blockers or anticoagulants may blunt physiologic response

Key signs:

Abdominal tenderness, guarding, rigidity, rebound (signs of peritoneal irritation)
Seatbelt sign (lap belt contusion): intra-abdominal injury in ~1/3 of cases
Gray-Turner sign (flank ecchymosis): retroperitoneal hemorrhage (can be delayed 12 h to days)
Cullen sign (periumbilical ecchymosis): retroperitoneal hemorrhage (delayed)
Distension: from hemoperitoneum, pneumoperitoneum, gastric dilation, or ileus
Unexplained hypotension after significant blunt trauma = intraperitoneal hemorrhage until proven otherwise

As many as 45% of blunt trauma patients thought to have a benign abdomen on initial exam are later found to have significant intra-abdominal injury (Tintinalli's).

Diagnostic Approach

Primary Survey and e-FAST

The extended FAST (e-FAST) is performed at the transition from primary to secondary survey in all patients. It detects free intraperitoneal fluid (hemoperitoneum) and is at least as sensitive and specific as portable chest X-ray for hemothorax/pneumothorax.

Unstable patient + positive e-FAST (hemoperitoneum) → immediate laparotomy.

Laboratory Tests

CBC: leukocytosis 12,000-20,000/mm³ can result from demargination (non-specific)
Metabolic acidosis: base deficit ≥ 6, lactate > 4 mmol/L, or decreasing bicarbonate suggest perfusion compromise
LFTs: elevated transaminases suggest hepatic injury (does not distinguish contusion from severe injury)
Amylase/lipase: NOT useful acutely - normal values do not exclude pancreatic injury, and elevated values are non-specific

Radiology

Portable chest X-ray (or e-FAST chest component): screen for hemothorax/pneumothorax before CT transfer
Plain abdominal films: not indicated in blunt trauma (except projectile localization)
Pelvic X-ray: may be omitted in hemodynamically stable patients heading directly to CT
CT abdomen/pelvis (with contrast): gold standard for the hemodynamically stable patient - identifies organ injuries, active hemorrhage (blush), retroperitoneal injury

CT limitations: Less sensitive for hollow viscus injury, diaphragmatic injuries, and some pancreatic injuries. Free fluid without a clear solid organ source warrants high suspicion for bowel injury.

Management Algorithm

Fig. 38.8 Blunt Abdominal Trauma (BAT) Algorithm - ROSEN's Emergency Medicine

Indications for Immediate Laparotomy (Blunt Trauma):

Absolute:

Anterior abdominal injury with hypotension
Abdominal wall disruption
Peritonitis
Free air under diaphragm on chest X-ray
Positive FAST or DPL in hemodynamically unstable patient
CT-diagnosed injury requiring surgery

Relative:

Positive FAST or DPL in hemodynamically stable patient
Solid visceral injury in stable patient
Hemoperitoneum on CT without clear source

Nonoperative Management

In hemodynamically stable patients, nonoperative management of blunt liver and spleen injuries has a 95% success rate - provided the institution has:

Trauma surgeons immediately available
Adequate blood bank resources
Radiologists capable of emergent angioembolization
Rapid transfer capability to OR

Critical caveat: Hollow viscus injury (bowel, bladder) requires operative management when present. It is easily missed on CT.

Special Considerations

Tranexamic acid: Consider in all patients with traumatic abdominal hemorrhage. Based on CRASH-2 trial: most benefit within 1 hour; administration beyond 3 hours increases risk of death. Should be available in all EDs managing trauma.
Anticoagulation reversal: Warfarin or factor Xa inhibitors (rivaroxaban, apixaban, edoxaban): prothrombin complex concentrate (PCC). Dabigatran: idarucizumab.
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): Available at Level 1 trauma centers for unresponsive shock from intra-abdominal hemorrhage; acts as endovascular aortic clamp.
Angioembolization: Advancing nonoperative option for vascular injuries; transcatheter coil or Gelfoam embolization to arrest hemorrhage.

Disposition

Significant intra-abdominal injury: admit to surgical/trauma service
Consider admission even for minor abdominal injury if concomitant injuries present
Discharge patients: thorough return precautions (fever, vomiting, increased pain, dizziness, weakness)

References: ROSEN's Emergency Medicine - Concepts and Clinical Practice, 9th ed. (Ch. 38, 136); Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9th ed. (Ch. 185, 263)

This is a shared conversation. Sign in to Orris to start your own chat.